Cameron Santoro on Muck Rack

Cameron Santoro

As seen in: MJH Life Sciences, EIN News, NewsBreak, American Journal of Managed Care, Dermatology Times, Managed Healthcare Executive, Drug Topics, Patient Care, Center for Biosimilars
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cameron

Contact Cameron, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Top 5 Biosimilar Articles for the Week of August 11

|
By Cameron Santoro
| Center for Biosimilars
August 15, 2025 Here are the top 5 biosimilar articles for the week of August 11, 2025. Number 5: Biosimilar insulin glargine struggles for market share in the UK, facing pricing challenges and prescriber inertia despite regulatory support and cost-saving potential. Number 4: Explore the latest biosimilar developments, including legislative changes, new approvals, and challenges in understanding, shaping the future of affordable health care.
Open in Who Shared Issue with article?

Denosumab Biosimilar LY01011 Shows Equivalence to Reference Product for Bone Metastases

|
By Cameron Santoro
| Center for Biosimilars
The efficacy of LY01011 in reducing the bone metabolism biomarker NTX was equivalent to that of the reference product denosumab (Xgeva; Amgen), thus meeting the primary end point with safety characteristics of LY01011 and denosumab similar, and no unexpected adverse reactions were reported, according to a study published in the Journal of Bone Oncology.1 Bone metastases, which cause an estimated 35,000 deaths in the US each year, have seen evolving treatment options for patients with cancer.2...
Open in Who Shared Issue with article?

The Top 5 Biosimilar Articles for the Week of August 4

|
By Cameron Santoro
| Center for Biosimilars
August 8, 2025 Here are the top 5 biosimilar articles for the week of August 4, 2025. Number 5: Biosimilars promise cost savings and improved patient access in Latin America, yet face significant regulatory and educational barriers hindering their uptake. Number 4: Patients with rheumatoid and psoriatic arthritis maintained stable disease activity and functional capacity, with even some improvement in ultrasound findings, after switching from original adalimumab to its biosimilar, GP2017.
Open in Who Shared Issue with article?
See all 242 licensed articles (777 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified